Suchergebnisse - "Peyrin-Biroulet, Laurent"

PubPharm (1.407)

31

Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis : Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Vermeire, S. | Feagan, B. | Peyrin-Biroulet, L. | +4

32

Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice : International Delphi Consensus Recommendations

enthalten in: Journal of Crohn's & colitis | 2024

von Schreiber, S. | Danese, S. | Dignass, A. | +13

33

The role of filgotinib in ulcerative colitis and Crohn's disease

enthalten in: Immunotherapy | 2024

von Fanizza, J. | D'Amico, F. | Lauri, G. | +9

34

Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials

enthalten in: Inflammatory bowel diseases | 2024

von D'Haens, G. | Higgins, P. | Peyrin-Biroulet, L. | +11

35

Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein : results from the Phase 2 OASIS trial

enthalten in: Journal of Crohn's & colitis | 2024

von Yarur, A. | Chiorean, M. | Panés, J. | +6

36

The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment : findings from a prospective real-world study in inflammatory bowel disease patients

enthalten in: Journal of Crohn's & colitis | 2024

von Magro, F. | Fernandes, S. | Patita, M. | +21

37

Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease : A Systematic Review and Network Meta-Analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Vuyyuru, S. | Nguyen, T. | Murad, M. | +9

38

Clinical trial : Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Peyrin‐Biroulet, L. | Vermeire, S. | D'Haens, G. | +15

39

The Role of IL-23 Inhibitors in Crohn's Disease

enthalten in: Journal of clinical medicine | 2023

von Fanizza, J. | D'Amico, F. | Lusetti, F. | +9

40

The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease

enthalten in: Inflammatory bowel diseases | 2023

von Swaminathan, A. | Fulforth, J. | Frampton, C. | +12